{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
{{facet.count}}
Status:
Possibly Marketed Outside US
Source:
NCT04677712: Phase 4 Interventional Completed Edematous Fibrosclerotic Panniculopathy (EFP)
(2020)
Source URL:
First approved in 2004
Source:
Salex by Coria Laboratories
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Phenoxyethanol, also known as Ethylene Glycol Monophenyl Ether, is a glycol ether and bactericide (that functions as a disinfectant, antiseptic or antibiotic) that is primarily used as a preservative in cosmetics and beauty products. It is used as a preservative in vaccines. Phenoxyethanol is included in topical antiseptic solutions, like octenisept used for the treatment of traumatic, acute, chronic, surgical and burn wounds, the treatment of bacterial vaginosis, acne lesions and as the mucous membrane antiseptic.
Status:
Possibly Marketed Outside US
Source:
NDA021643
(2004)
Source URL:
First approved in 2004
Source:
NDA021643
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Conditions:
Gentisic acid ethanolamide is a complexing agent in pharmaceutical parenterals. It is used as a solubilizer in some pharmaceutical preparations and as an antiseptic agent.
Status:
Possibly Marketed Outside US
Source:
21 CFR 348
(2004)
Source URL:
First approved in 2004
Source:
21 CFR 348
Source URL:
Class (Stereo):
CHEMICAL (ABSOLUTE)
NAG-thiazoline (NGT) and its derivatives are well-known inhibitors against most b-acetylglucosaminidases (b-GlcNAcases) except for insect and bacterial chitinolytic b-GlcNAcase. Among them, NGT was the only one specifically designed to be an analog of the oxazolinium reaction intermediate based on the substrate-assisted mechanism, an attractive starting point to develop potent inhibitors. It is a major building block for the synthesis of potential inhibitors of transglycosylases involved in bacterial cell wall biosynthesis.
Status:
Possibly Marketed Outside US
Source:
CIS-MDP by Schwarzenbach, G.|Zurc, J.
Source URL:
First approved in 2004
Source:
NDA018035
Source URL:
Class (Stereo):
CHEMICAL (ACHIRAL)
Targets:
Conditions:
Medronic acid (conjugate base, medronate) is a diagnostic agent that is used in complex with technetium Tc-99m for imaging delineate areas of altered osteogenesis. Upon administration the complex binds to hydroxyapatite crystals in bone.
Status:
US Previously Marketed
Source:
ENJUVIA by DURAMED
(2004)
Source URL:
First approved in 2004
Source:
ENJUVIA by DURAMED
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M003
(2004)
Source URL:
First approved in 2004
Source:
M003
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
M003
(2017)
Source URL:
First approved in 2004
Source:
21 CFR 358H
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
21 CFR 333D
(2010)
Source URL:
First approved in 2004
Source:
M032
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
NDA021361
(2004)
Source URL:
First approved in 2004
Source:
NDA021361
Source URL:
Class:
MIXTURE
Status:
Possibly Marketed Outside US
Source:
ANDA076903
(2004)
Source URL:
First approved in 2004
Source:
ANDA076903
Source URL:
Class:
MIXTURE